Results 21 to 30 of about 2,774 (159)

Late-Onset Isolated Vitreous Hemorrhage After Micropulse Transscleral Cyclophotocoagulation: A Case Report and Insights for a Rare Complication. [PDF]

open access: yesMed Devices (Auckl)
Wisam Shihadeh,1 Abdelwahab Aleshawi,1 Yara Aburamadan,2 Mohammed Al-Shalakhti,3 Amr Abu Najm,1 Ala’ Y’ Ibrahim3 1Division of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110 ...
Shihadeh W   +5 more
europepmc   +2 more sources

The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial

open access: yesTrials, 2022
Background At present, intraocular injection of anti-VEGF (vascular endothelial growth factor) drugs has replaced traditional laser therapy as the first-line treatment for DME (diabetic macular edema). However, ranibizumab, a commonly used anti-VEGF drug,
Xuejing Mi, Xiaoya Gu, Xiaobing Yu
doaj   +1 more source

A review on technology and different probes in transscleral cyclophotocoagulation

open access: yesTNOA Journal of Ophthalmic Science and Research, 2022
Glaucoma is a chronic progressive optic neuropathy, characterised by retinal ganglion cell loss leading to optic nerve head changes and visual field defects.
M Salu   +3 more
doaj   +1 more source

Subthreshold micropulse yellow 577 nm laser therapy of diabetic macular oedema in rural and urban patients of south-eastern Poland [PDF]

open access: yes, 2017
Objectiv To evaluate the efficacy of subthreshold micropulse yellow (577 nm) laser photocoagulation in diffuse macular edema (DME) in rural and urban patients of south-eastern Poland.
Dominika Wróbel-Dudzińska   +7 more
core   +2 more sources

Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review

open access: yes, 2022
Diabetic macular edema (DME) is one of the main causes of visual impairment in patients of working age. DME occurs in 4% of patients at all stages of diabetic retinopathy.
Edward Wylęgała   +2 more
core   +1 more source

Subthreshold micropulse yellow laser in the treatment of central serous chorioretinopathy

open access: yesTNOA Journal of Ophthalmic Science and Research, 2019
Purpose: The objective was to study the safety and efficacy of subthreshold micropulse yellow laser in the treatment of central serous chorioretinopathy (CSCR).
T P Vignesh
doaj   +1 more source

Micropulse laser trabeculoplasty for open-angle glaucoma

open access: yesDelta Journal of Ophthalmology, 2016
Purpose The aim of this study was to evaluate the pressure-lowering effect of 577 nm micropulse laser trabeculoplasty in eyes treated for primary open-angle glaucoma. Patients and methods This prospective interventional case series included 30 eyes of 30
Mahmoud A Abouhussein
doaj   +1 more source

Subthreshold yellow micropulse laser for treatment of diabetic macular edema: Comparison between fixed and variable treatment regimen

open access: yes, 2021
Purpose: To compare the efficacy between fixed and variable treatment regimens of subthreshold yellow micropulse laser for the treatment of diabetic macular edema. Methods: This is a retrospective, comparative, 12-month study of 39 eyes: 24 eyes received
Rizzo S., Virgili G.
core   +1 more source

Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes [PDF]

open access: yes, 2020
Precis: Micropulse trans-scleral cyclophotocoagulation (TSCPC) is an effective and safe IOP-lowering treatment for patients with primary or secondary glaucoma.
Tos T.J.M. Berendschot   +18 more
core   +3 more sources

The micropulse framework for adaptive waking windows in sensor networks [PDF]

open access: yes, 2008
In this paper we present MicroPulse, a novel framework for adapting the waking window of a sensing device S based on the data workload incurred by a query Q.
Samaras, George   +4 more
core   +5 more sources

Home - About - Disclaimer - Privacy